Dr. Salvador Plasencia, who ran an urgent-care clinic outside Los Angeles, pleaded guilty to four felony counts of illegal distribution of the prescription anestheticDr. Salvador Plasencia, who ran an urgent-care clinic outside Los Angeles, pleaded guilty to four felony counts of illegal distribution of the prescription anesthetic

Doctor in Matthew Perry overdose case sentenced to 2-1/2 years in prison

2025/12/04 13:51

LOS ANGELES, USA – A California doctor was sentenced to 2-1/2 years in prison on Wednesday for illegally supplying Friends sitcom star Matthew Perry with ketamine, the powerful sedative that caused the actor’s drug overdose death in 2023.

Dr. Salvador Plasencia, 44, who ran an urgent-care clinic outside Los Angeles, pleaded guilty in federal court in July to four felony counts of illegal distribution of the prescription anesthetic. He could have faced up to 40 years in prison for the crime.

Perry was found by his live-in assistant floating face down and lifeless in the jacuzzi of his Los Angeles home on October 28, 2023. He was 54. An autopsy report concluded the actor died from the “acute effects of ketamine,” which combined with other factors in causing the actor to lose consciousness and drown.

Ketamine is a short-acting anesthetic with hallucinogenic properties that is sometimes prescribed to treat depression and other psychiatric disorders. It also has seen widespread abuse as an illicit party drug.

Plasencia, who surrendered his medical license in September, admitted as part of his plea agreement that in the weeks before Perry’s death he had injected the actor with ketamine on multiple occasions at the actor’s home and once in the back seat of a parked car. 

Perry had publicly acknowledged decades of substance abuse, including the years he starred as Chandler Bing on the hit 1990s NBC television series Friends.

According to federal law enforcement officials, Perry had been receiving ketamine infusions for treatment of depression and anxiety at a clinic where he became addicted to the drug.

When doctors there refused to increase his dosage, he turned to unscrupulous providers elsewhere willing to exploit Perry’s drug dependency as a way to make quick money, authorities said.

Plasencia, who practiced medicine in the Los Angeles suburb of Calabasas, said he was introduced to Perry through a patient acquainted with the doctor and obtained the ketamine from another doctor, co-defendant Mark Chavez of San Diego. According to court filings, Plasencia once texted Chavez about Perry, writing, “I wonder how much this moron will pay.”

Within weeks, Perry was dead from an overdose of ketamine supplied by yet another co-defendant – a drug dealer known as the “Ketamine Queen” – and injected by the actor’s personal assistant, Kenneth Iwamasa.

“You and others helped Mr. Perry stay on the road to such an ending while continuing to feed his addiction,” US District Judge Sherilyn Peace Garnett said before sentencing Plasencia to 30 months in prison and a $5,600 fine.

Addressing the court before the judge imposed sentence on Wednesday, amid audible sobs from his mother and Perry’s relatives, Plasencia expressed remorse and said he took full responsibility for his actions.

“I failed Mr. Perry, I failed his family, and I failed the community,” he said, before turning to directly face members of Perry’s family seated in the courtroom and adding, “I’m just so sorry.”

Delivering a victim impact statement earlier in the proceeding, Perry’s mother, Suzanne Morrison, said, “There is an oath that doctors take, and I think it really got forgotten.” Looking directly at Plasencia, she said, “I want you to see this is the mother” and added “this was a bad thing to do.”

Four other defendants – Chavez, 55, Iwamasa, 60, Jasveen Sangha, 42, aka “Ketamine Queen,” and go-between dealer Erik Fleming, 56 – have pleaded guilty in connection with Perry’s death and are scheduled to be sentenced in the coming weeks. – Rappler.com

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Spot XRP ETFs Nears $1B AUM Milestone as Streak of No Outflows Continues

Spot XRP ETFs Nears $1B AUM Milestone as Streak of No Outflows Continues

The post Spot XRP ETFs Nears $1B AUM Milestone as Streak of No Outflows Continues appeared on BitcoinEthereumNews.com. The U.S. Spot XRP ETFs is now near the $1 billion mark of assets under management in less than a month since their launch. This follows from the product maintaining consistent inflows with no single outflow recorded yet. XRP ETFs See Continuous Inflows Since Launch Since its first launch on November 14, spot XRP funds have seen continued inflows. According to data from SoSoValue, the total inflows into these funds have now risen to $881.25 million. The funds attracted $12.84 million of new money yesterday. The daily trading volumes remained stable at $26.74 million. Source: SoSoValue Reaching nearly $1 billion in less than 30 days makes the product among the fastest growing crypto investment products in the United States. Notably, Spot Solana ETFs also accumulated over $600 million since their launch. On the other hand, Bitcoin and Ethereum ETFs are holding about $58 billion and about $13 billion in assets under management respectively. Much of the early growth traces back to the first Canary Capital’s XRP ETF. Its opening on November 13 brought one of the strongest crypto ETF openings to date. It saw more than $59 million in first-day trading volume and $245 million in net inflows. Shortly after Canary’s launch, firms like Grayscale, Bitwise, and Franklin Templeton introduced their own XRP products. Bitwise’s fund also did well on its launch, recording over $105 million in early inflows. Meanwhile, the market is getting ready for yet another addition. 21Shares’ U.S. spot XRP fund also got the green light from the SEC. It will trade under the ticker TOXR on the Cboe BZX Exchange. XRP Products Keep Gaining Momentum in the Market The token’s funds continued to expand this week. REX Shares and Tuttle Capital have launched the T-REX 2X Long XRP Daily Target ETF. This new ETF allows traders…
Share
BitcoinEthereumNews2025/12/05 14:11